Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning - PubMed
Review
Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning
Péter Ferdinandy et al. Br J Pharmacol. 2003 Feb.
Abstract
There appears to be a controversy in the study of myocardial ischaemia-reperfusion injury and preconditioning whether nitric oxide (NO) plays a protective or detrimental role. A number of findings and the interpretation of the results to date do not support such a controversy. An understanding of the latest developments in NO, superoxide (O(2)(-)*) and peroxynitrite (ONOO(-)) biology, as well as the various ischaemic animal models utilized is necessary to resolve the apparent controversy. NO is an important cardioprotective molecule via its vasodilator, antioxidant, antiplatelet, and antineutrophil actions and it is essential for normal heart function. However, NO is detrimental if it combines with O(2)(-)* to form ONOO(-) which rapidly decomposes to highly reactive oxidant species. There is a critical balance between cellular concentrations of NO, O(2)(-)*, and superoxide dismutase which physiologically favour NO production but in pathological conditions such as ischaemia and reperfusion result in ONOO(-) formation. In contrast, exposure of the heart to brief episode(s) of ischaemia markedly enhances its ability to withstand a subsequent ischaemic injury. The triggering of this endogenous cardioprotective mechanism known as preconditioning requires both NO and O(2)(-)* synthesis. However, preconditioning in turn attenuates the overproduction of NO, O(2)(-)* and ONOO(-) during a subsequent episode of ischaemia and reperfusion, thereby protecting the heart. Here we review the roles of NO, O(2)(-)*, and ONOO(-) in both ischaemia-reperfusion injury and preconditioning.
Figures

Cellular mechanisms of nitric oxide (NO), superoxide (O2−·), and peroxynitrite (ONOO−) actions. NO is an important cardioprotective molecule via its vasodilator, antioxidant, antiplatelet, and antineutrophil actions and it is essential for normal heart function. However, NO is detrimental if it combines with O2−· to form ONOO− which rapidly decomposes to highly reactive oxidant species leading to tissue injury. There is a critical balance between cellular concentrations of NO, O2−·, and superoxide dismutase (SOD) which physiologically favor NO production but in pathological conditions such as ischaemia and reperfusion result in ONOO− formation. ONOO− is detoxified if it combines with reduced glutathione (GSH) or other thiols to form S-nitrosoglutathione (GSNO) or other nitrosothials, an NO donor molecule. MMP – matrix metalloproteinase; NOS – NO synthase; PARP – poly-ADP ribose synthase; XOR – xanthine oxidoreductase.

Increased synthesis of nitric oxide (NO) and superoxide (O2−·) leads to a pronounced formation of the toxic metabolite peroxynitrite (ONOO−) upon reperfusion thereby leading to myocardial injury (A). Preceding short periods of ischaemia/reperfusion during preconditioning, however, results in a moderate formation of reactive oxygen species which triggers a cardioprotective mechanism leading to subsequent inhibition of ONOO− formation (B). A similar mechanism is suspected during late preconditioning, however, expression of iNOS and antioxidant enzymes such as superoxide dismutase (SOD) also occurs. Changes in cardiac NO, O2−·, and ONOO− and the exact role of increased iNOS are questions of debate (C). Bars denote periods of ischaemia, arrows indicate formation of reactive oxygen species upon reperfusion or expression of enzymes, font size shows relative amount of NO, O2−·, and ONOO− formation.
Similar articles
-
Juhász L, Kiss A, Nyeso E, Kovács M, Seprényi G, Kaszaki J, Végh A. Juhász L, et al. Eur J Pharmacol. 2011 Sep 30;667(1-3):306-13. doi: 10.1016/j.ejphar.2011.06.010. Epub 2011 Jun 16. Eur J Pharmacol. 2011. PMID: 21699894
-
The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts.
Turan N, Csonka C, Csont T, Giricz Z, Fodor G, Bencsik P, Gyöngyösi M, Cakici I, Ferdinandy P. Turan N, et al. Cardiovasc Res. 2006 May 1;70(2):384-90. doi: 10.1016/j.cardiores.2005.12.012. Epub 2006 Jan 27. Cardiovasc Res. 2006. PMID: 16443208
-
Hallström S, Franz M, Gasser H, Vodrazka M, Semsroth S, Losert UM, Haisjackl M, Podesser BK, Malinski T. Hallström S, et al. Cardiovasc Res. 2008 Feb 1;77(3):506-14. doi: 10.1093/cvr/cvm052. Epub 2007 Oct 30. Cardiovasc Res. 2008. PMID: 18006447
-
Role of nitric oxide and oxidative stress in ischaemic myocardial injury and preconditioning.
Berges A, Van Nassauw L, Bosmans J, Timmermans JP, Vrints C. Berges A, et al. Acta Cardiol. 2003 Apr;58(2):119-32. doi: 10.2143/AC.58.2.2005264. Acta Cardiol. 2003. PMID: 12715903 Review.
-
Ferdinandy P, Schulz R, Baxter GF. Ferdinandy P, et al. Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29. Pharmacol Rev. 2007. PMID: 18048761 Review.
Cited by
-
Fluid Mechanical Forces and Endothelial Mitochondria: A Bioengineering Perspective.
Scheitlin CG, Nair DM, Crestanello JA, Zweier JL, Alevriadou BR. Scheitlin CG, et al. Cell Mol Bioeng. 2014 Dec;7(4):483-496. doi: 10.1007/s12195-014-0357-4. Cell Mol Bioeng. 2014. PMID: 25530817 Free PMC article.
-
Pabla R, Curtis MJ. Pabla R, et al. Br J Pharmacol. 2007 Apr;150(7):893-8. doi: 10.1038/sj.bjp.0707143. Epub 2007 Feb 12. Br J Pharmacol. 2007. PMID: 17293889 Free PMC article.
-
Mukhopadhyay P, Pan H, Rajesh M, Bátkai S, Patel V, Harvey-White J, Mukhopadhyay B, Haskó G, Gao B, Mackie K, Pacher P. Mukhopadhyay P, et al. Br J Pharmacol. 2010 Jun;160(3):657-68. doi: 10.1111/j.1476-5381.2010.00769.x. Br J Pharmacol. 2010. PMID: 20590569 Free PMC article.
-
Wang S, Dusting GJ, May CN, Woodman OL. Wang S, et al. Br J Pharmacol. 2004 Jun;142(3):443-52. doi: 10.1038/sj.bjp.0705815. Epub 2004 May 17. Br J Pharmacol. 2004. PMID: 15148246 Free PMC article.
-
Grotthus B, Szeląg A. Grotthus B, et al. J Exp Pharmacol. 2019 Dec 23;11:149-158. doi: 10.2147/JEP.S209085. eCollection 2019. J Exp Pharmacol. 2019. PMID: 31920405 Free PMC article.
References
-
- ALTUG S., DEMIRYUREK A.T., AK D., TUNGEL M., KANZIK I. Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts. Eur. J. Pharmacol. 2001;415:239–246. - PubMed
-
- ARSTALL M.A., SAWYER D.B., FUKAZAWA R., KELLY R.A. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ. Res. 1999;85:829–840. - PubMed
-
- BAXTER G.F. The neutrophil as a mediator of myocardial ischaemia-reperfusion injury: time to move on. Basic Res. Cardiol. 2002;97:268–275. - PubMed
-
- BAXTER G.F., FERDINANDY P. Delayed preconditioning of myocardium: current perspectives. Basic Res. Cardiol. 2001;96:329–344. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources